Precigen (PGEN) Shares Outstanding (Weighted Average) (2016 - 2025)

Precigen (PGEN) has disclosed Shares Outstanding (Weighted Average) for 14 consecutive years, with $307.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 11.34% to $307.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $307.2 million, a 11.34% increase, with the full-year FY2024 number at $267.7 million, up 9.48% from a year prior.
  • Shares Outstanding (Weighted Average) was $307.2 million for Q3 2025 at Precigen, up from $296.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $307.2 million in Q3 2025 to a low of $193.5 million in Q1 2021.
  • A 5-year average of $236.7 million and a median of $244.5 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): rose 24.1% in 2023, then rose 1.13% in 2024.
  • Precigen's Shares Outstanding (Weighted Average) stood at $197.8 million in 2021, then rose by 1.32% to $200.4 million in 2022, then grew by 22.05% to $244.5 million in 2023, then increased by 9.48% to $267.7 million in 2024, then rose by 14.73% to $307.2 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Shares Outstanding (Weighted Average) are $307.2 million (Q3 2025), $296.4 million (Q2 2025), and $293.9 million (Q1 2025).